dpp 4 inhibitors glp 1 DPP4 Inhibitor Mechanism of Action – My Endo Consult Insights into the Roles of

Learn about Noom's GLP-1 Companion in this informative video, offering insight and resources to help close the care gap for your GLP-1 population.

Amgen is taking their own approach to weight loss with their investigational obesity drug #MariTide

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), approved for diabetes and obesity, have shown promise in modulating reward-related brain pathways, suggesting potential benefits in the management of AUD

Theyre Talking About Cost

This state-of-the-art narrative review synthesizes current evidence from clinical trials, pharmacovigilance databases, and real-world cohorts to provide a comprehensive evaluation of the safety and tolerability of GLP-1RAs and tirzepatide